Role of the outer membrane in the accumulation of quinolones by Serratia marcescens

Canadian Journal of Microbiology

Volumn 46, Issue 8, 2000, Pages 716-722

  Berlanga, M ^a   Ruiz, N ^a   Hernandez Borrell, J ^a   Montero, T ^a   Vinas, M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OUTER MEMBRANE PROTEIN; PIPEMIDIC ACID; PORIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL OUTER MEMBRANE; DRUG ACCUMULATION; DRUG PENETRATION; DRUG UPTAKE; ESCHERICHIA COLI; HYDROPHOBICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SERRATIA MARCESCENS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; SERRATIA MARCESCENS;

EID: 0033842697     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/w00-052     Document Type: Article

References (46)

1. Trends in bacterial resistance to fluoroquinolones
2. Evidence for an efflux pump in Serratia marcescens
3. Classification and structure-activity relationships of fluoroquinolones
4. Routes of quinolone permeation in Escherichia coli
5. Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni
6. Cross-resistance to fluoroquinolones in multiple antibiotic resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: Decreased drug accumulation associated with membrane changes in addition to OmpF reduction
7. Cloning and expression in Escherichia coli K12 of the genes for major outer membrane protein OmpA from Shigella dysenteriae, Enterobacter aerogenes and Serratia marcescens
8. Structure-activity relationships of the quinolones
9. Association of Escherichia coli K-12 OmpF trimers with rough and smooth lipopolysaccharide
10. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane
11. Quinolone resistance in clinical isolates of Serratia marcescens
12. Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone susceptible Staphylococcus aureus
13. Epidemiology of quinolone resistance: Europe and North and South America
14. Cross resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alteration in outer membrane proteins of Klebsiella, Enterobacter and Serratia
15. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli
16. Isolation and characterization of norfloxacin resistant mutants of Escherichia coli
17. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver stained polyacrylamide gels
18. Mechanisms of quinolone resistance in Escherichia coli: Characterization of nfxB and cfxB two mutant resistance loci decreasing norfloxacin accumulation
19. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
20. Cloning and expression in Escherichia coli of a gene encoding proline oxidase of Serratia marcescens
21. Interaction of divalent cations, quinolones and bacteria
22. Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus
23. Structure-activity relationships
24. Influence of physicochemical properties of fluoroquinolones on encapsulation efficiency in liposomes
25. Fluoroquinolone biomembrane interactions: Monolayer and calorimetric studies
26. A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriae, Pseudomonas aeruginosa and Staphylococcus aureus
27. Molecular basis of bacterial outer membrane permeability
28. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: Tetracyclines and quinolones as examples
29. Detection of gyrA and gyrB mutations in quinolone resistant clinical isolates of Escherichia coli by simple strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations
30. The role of O-antigen in susceptibility of Serratia marcescens to non-immune serum
31. Phenotypic characterization of quinolone resistant mutant of Enterobacteriaceae selected from wild type, gyrA type and multiply resistant (marA) type strains
32. Outer membrane proteins from Serratia marcescens
33. Physicochemical properties of the fluoroquinolone antimicrobials. 1-Octanol/water partition coefficients and their relationship to structure
34. Lipopolysaccharide structure required for in vitro trimerization of the Escherichia coli OmpF porin
35. Ionization constants of cephalosporins zwitterionic compounds
36. Incomplete cross-resistance of nalidixic and pipemidic acid resistant variants of Serratia marcescens against ciprofloxacin, enoxacin and norfloxacin
37. Isolation from urine of two Serratia marcescens strains excreting a diffusible yellow pigment
38. A sensitive silver stain for detecting lipopolysaccharide in polyacrilamide gels
39. 6-Fluoroquinolone liposome interactions: Fluorescence quenching study using iodine
40. Detection of mutations in parC in quinolone resistant clinical isolates of Escherichia coli
41. Quinolone resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumanii
42. In vitro emergence of quinolone resistant mutant of Escherichia coli, Enterobacter cloacae, and Serratia marcescens
43. gyrA Mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae
44. The pigment of Serratia
45. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: Resistance to tetracycline, chloramphenicol, and norfloxacin
46. DNA and amino acid sequences of outer membrane proteins and lipoproteins